Selling And Administration Expenses változás Dátum
Abbott USD 2.69B 10M 2023-12
AngioDynamics USD 38.22M 1.7M 2023-06
AtriCure USD 67.69M 6.82M 2023-12
Avanos Medical USD 78.7M 14M 2023-09
Baxter International USD 832M 47M 2023-12
Becton, Dickinson and Co. USD 1.21B 75M 2023-12
Boston Scientific USD 1.38B 137M 2023-12
Cooper Companies USD 380.9M 6.7M 2023-12
Dexcom USD 300.7M 16M 2023-12
Edwards Lifesciences USD 480M 40.4M 2023-12
Globus Medical USD 244.72M 88.51M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
ICU Medical USD 154.34M 6.01M 2023-12
Inogen USD 43.1M 1.58M 2023-09
Insulet USD 212.8M 32.1M 2023-12
Integra LifeSciences USD 146.52M 1.13M 2023-12
Intuitive Surgical USD 567.1M 115.9M 2023-12
J&J USD 5.81B 410M 2023-12
Laboratory Of America USD 532.9M 7.4M 2023-12
Masimo USD 159.9M 3.8M 2023-12
Merit Medical Systems USD 95.75M 8.9M 2023-12
Quest Diagnostics USD 400M 24M 2023-12
Smith & Nephew USD 1.32B 1000K 2023-06
Stryker USD 1.8B 125M 2023-12
Tandem Diabetes Care USD 85.75M 6.42M 2023-12
Teleflex USD 260.65M 47.46M 2023-12
Terumo JPY 82.76B 2.27B 2023-09
Zimmer Biomet Holdings USD 722.3M 50.1M 2023-12



Baxter International Értékesítési És Adminisztrációs Költségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.